Raptor Pharmaceutical Corp - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 2, 2015

Attached files

file filename
EX-23.2 - EXHIBIT 23.2 - Raptor Pharmaceutical Corpex23_2.htm
EX-31.1 - EXHIBIT 31.1 - Raptor Pharmaceutical Corpex31_1.htm
EX-32.1 - EXHIBIT 32.1 - Raptor Pharmaceutical Corpex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Raptor Pharmaceutical Corpex31_2.htm
EX-21.1 - EXHIBIT 21.1 - Raptor Pharmaceutical Corpex21_1.htm
EX-10.46 - EXHIBIT 10.46 - Raptor Pharmaceutical Corpex10_46.htm
EX-10.49 - EXHIBIT 10.49 - Raptor Pharmaceutical Corpex10_49.htm
EX-10.48 - EXHIBIT 10.48 - Raptor Pharmaceutical Corpex10_48.htm
EX-10.50 - EXHIBIT 10.50 - Raptor Pharmaceutical Corpex10_50.htm
EX-10.47 - EXHIBIT 10.47 - Raptor Pharmaceutical Corpex10_47.htm
EXCEL - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpFinancial_Report.xls
10-K - RAPTOR PHARMACEUTICAL, CORP 10-K 12-31-2014 - Raptor Pharmaceutical Corpform10k.htm
EX-10.45 - EXHIBIT 10.45 - Raptor Pharmaceutical Corpex10_45.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 2, 2015, with respect to the consolidated financial statements, schedule and internal control over financial reporting, included in the Annual Report of Raptor Pharmaceutical Corp. on Form 10-K for the year ended December 31, 2014. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Raptor Pharmaceutical Corp. on Forms S-3 (File Nos. 333-198599, 333-195885, and 333-162430) and on Forms S-8 (File Nos. 333-198186, 333-190806, 333-173719, 333-166813, 333-163124, 333-151859, 333-141738, 333-138368, 333-118729, 333-103129, 333-98245 and 333-48088).

/s/ GRANT THORNTON LLP

San Francisco, California
March 2, 2015
 

Raptor Pharmaceutical Corp Reports